Literature DB >> 23761420

Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain.

Siu Hing Lo1, Jo Waller, Jane Wardle, Christian von Wagner.   

Abstract

OBJECTIVE: Uptake of cancer screening tends to be lower for colorectal cancer (CRC) than cervical or breast cancer. Dislike of the test itself has often been identified as a barrier to CRC screening with the Faecal Occult Blood (FOB) test, but there have been no head-to-head comparisons of the three tests.
METHODS: Women aged 50-80 (n = 890) were recruited in spring 2012 as part of a population-based TNS Research International survey in Great Britain. Those in the eligible age range were asked if they had ever participated in breast, cervical or CRC screening. For each screening test, women who had never participated were asked for their 'main reason' using a checklist of barriers.
RESULTS: Among eligible women, 67%, 83% and 90% reported ever having been screened for CRC, cervical and breast cancer respectively. More socioeconomically deprived women were less likely to report any screening, and single women were less likely to report CRC or breast screening than married women. Age was not associated with participation. Overall there were few differences between tests in the reported barriers, but dislike of the test was endorsed more often for CRC screening.
CONCLUSION: This was the first study to compare barriers to participation in organised screening programmes for CRC, breast and cervical cancer. Cancer screening tests share many barriers, but dislike of the test appears to be a stronger barrier to CRC screening. Women who are non-participants in more than one programme may have more global barriers to screening, such as cancer fatalism. The findings suggest that uptake of CRC screening could be improved by targeting the unpleasantness of stool sampling.

Entities:  

Mesh:

Year:  2013        PMID: 23761420     DOI: 10.1177/0969141313492508

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  21 in total

1.  Correlates of perceived risk of developing cancer among African-Americans in South Los Angeles.

Authors:  Anna Lucas-Wright; Mohsen Bazargan; Loretta Jones; Jaydutt V Vadgama; Roberto Vargas; Marianna Sarkissyan; James Smith; Hamed Yazdanshenas; Annette E Maxwell
Journal:  J Community Health       Date:  2014-02

Review 2.  Clinical applications of liquid biopsies in gastrointestinal oncology.

Authors:  Jason Zhu; John H Strickler
Journal:  J Gastrointest Oncol       Date:  2016-10

3.  Does mailing unsolicited HPV self-sampling kits to women overdue for cervical cancer screening impact uptake of other preventive health services in a United States integrated delivery system?

Authors:  Hitomi Kariya; Diana S M Buist; Melissa L Anderson; John Lin; Hongyuan Gao; Linda K Ko; Rachel L Winer
Journal:  Prev Med       Date:  2021-11-17       Impact factor: 4.018

4.  Sociodemographic correlates of colorectal cancer screening completion among women adherent to mammography screening guidelines by place of birth.

Authors:  Deeonna E Farr; Leslie E Cofie; Alison T Brenner; Ronny A Bell; Daniel S Reuland
Journal:  BMC Womens Health       Date:  2022-04-21       Impact factor: 2.742

5.  Micro actions in colorectal cancer screening participation: a population-based survey study.

Authors:  Siu Hing Lo; Jo Waller; Charlotte Vrinten; Christian von Wagner
Journal:  BMC Cancer       Date:  2015-05-29       Impact factor: 4.430

6.  Variation in cervical and breast cancer screening coverage in England: a cross-sectional analysis to characterise districts with atypical behaviour.

Authors:  Nathalie J Massat; Elaine Douglas; Jo Waller; Jane Wardle; Stephen W Duffy
Journal:  BMJ Open       Date:  2015-07-24       Impact factor: 2.692

7.  Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women.

Authors:  R G Blanks; V S Benson; R Alison; A Brown; G K Reeves; V Beral; J Patnick; J Green
Journal:  Br J Cancer       Date:  2015-03-05       Impact factor: 7.640

8.  The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes.

Authors:  L Mead; L Porteous; M Tait; R Stoker; S Payne; C Calvert; D Maxwell; S V Katikireddi
Journal:  J Med Screen       Date:  2015-03-09       Impact factor: 2.136

9.  A randomised trial of weekend and evening breast screening appointments.

Authors:  J Offman; M Wilson; M Lamont; H Birke; E Kutt; S Marriage; Y Loughrey; S Hudson; A Hartley; J Smith; B Eckersley; F Dungey; D Parmar; J Patnick; S W Duffy
Journal:  Br J Cancer       Date:  2013-07-18       Impact factor: 7.640

10.  Anticipated regret to increase uptake of colorectal cancer screening (ARTICS): A randomised controlled trial.

Authors:  Ronan E O'Carroll; Julie A Chambers; Linda Brownlee; Gillian Libby; Robert J C Steele
Journal:  Soc Sci Med       Date:  2015-07-27       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.